Through 2020, the MedTech industry faced a sizable drop in elective and non-COVID-19 procedures. However, the tables turned in the second half of 2020. This change came on the back of the launch of several COVID-19 diagnostic tests, shift of consumer preferences toward digital healthcare options as well as a steady uptick in emergency medical procedures. Major MedTech players like Abbott Laboratories...
Read Full Story
Trending News
Trending News
, 3min
0